Vr Adviser, LLC Aligos Therapeutics, Inc. Transaction History

Vr Adviser, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$14.57 - $17.72 $5.95 Million - $7.24 Million	-408,377 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$19.1 - $34.94 $66,296 - $121,276	3,471 Added 0.86%	408,377 $9.29 Million
Q4 2020 Feb 12, 2021	BUY	$13.2 - $32.74 $5.34 Million - $13.3 Million	404,906 New	404,906 $11.2 Million

227K

Ticker ALGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,717,000
Market Cap $1.03B
Description
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

Stay updated on Vr Adviser, LLC with notifications on news.